Nile Pharmaceuticals

مادة اعلانية

Latest Update: 21 Nov 2024 16:26 Abu Dhabi Time.

Market Status: Closed

NIPH

Nile Pharmaceuticals

55.22

EGP

-2.850

-4.91%

Open

58.07

Prev Close

58.07

PX_VOLUME

168,129

MARKET CAP (M)

DAY RANGE

54.50 - 58.99

52 WEEKS

25.86 - 75.30

Stock Statistics

Yearly Change

96.98%

Listed Shares (Million)

30.00

Earnings Multiple

16.38

Average 30-day trading volume

Price-to-book ratio

3.15

Earnings Per Share

3.55

Previous Dividend Distribution

Dividend Yield

3.43%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		79.23	296.69	387.93	378.73
Gross Profit		-22.98	66.54	99.51	109.37
Operating Income		-45.43	42.77	64.98	81.19
Profit Margin		-40.59	8.89	10.87	14.22

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Revenue	1,142.58	1,005.22
Gross Profit	252.43	271.81
Operating Income	143.52	162.76
Profit Margin	7.90	11.86

Balance Sheet

	Period Ending:	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Assets		1,473.19	1,420.28	1,201.86	1,106.13	1,038.29
Total Liabilities		1,004.34	905.13	710.54	573.80	559.81
Total Equity		468.86	515.14	491.33	532.32	478.48

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Assets	1,473.19	1,038.29
Total Liabilities	1,004.34	559.81
Total Equity	468.86	478.48

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.